Practical Geriatrics ›› 2025, Vol. 39 ›› Issue (5): 508-513.doi: 10.3969/j.issn.1003-9198.2025.05.015
Previous Articles Next Articles
ZHANG Dongmei, ZHANG Jing, ZHAO Zhenwei, LIU Peng, ZHANG Yongjian
Received:
2024-08-05
Online:
2025-05-20
Published:
2025-05-20
CLC Number:
ZHANG Dongmei, ZHANG Jing, ZHAO Zhenwei, LIU Peng, ZHANG Yongjian. Expression of SKp2, P27Kip1 and HLA-DRA protein in cancer tissues of elderly patients with colorectal cancer and their relationship with prognosis[J]. Practical Geriatrics, 2025, 39(5): 508-513.
[1] PATEL S G, KARLITZ J J, YEN T, et al. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection[J]. Lancet Gastroenterol Hepatol, 2022, 7(3): 262-274. [2] MURPHY C C, ZAKI T A. Changing epidemiology of colorectal cancer-birth cohort effects and emerging risk factors[J]. Nat Rev Gastroenterol Hepatol, 2024, 21: 25-34. [3] FAN H, WEN R, ZHOU L, et al. Clinicopathological features and prognosis of synchronous and metachronous colorectal cancer: a retrospective cohort study[J]. Int J Surg, 2023, 109(12): 4073-4090. [4] LIAO C, HUANG W, LIN M, et al. Correlation of KMT2 family mutations with molecular characteristics and prognosis in colorectal cancer[J]. Int J Biol Markers, 2022, 37(2): 149-157. [5] GAN Y, ZHOU L, WANG R, et al. Curcumol reduces aerobic glycolysis and overcomes chemoresistance by inducing Cdh1-mediated Skp2 ubiquitination[J]. Am J Chin Med, 2023, 51(3): 723-740. [6] LIU M, XU X, PENG K, et al. Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway[J]. Oncogenesis, 2022, 11(1): 58. [7] MORAFRAILE E C, SAIZ-LADERA C, NIETO-JIMÉNEZ C, et al. Mapping immune correlates and surfaceome genes in BRAF mutated colorectal cancers[J]. Curr Oncol, 2023, 30(3): 2569-2581. [8] 中华人民共和国卫生和计划生育委员会医政医管局, 中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2017年版)[J]. 中华外科杂志, 2018, 56(4):241-258. [9] YANG L, XU F. A novel anoikis-related risk model predicts prognosis in patients with colorectal cancer and responses to different immunotherapy strategies[J]. J Cancer Res Clin Oncol, 2023, 149(12): 10879-10892. [10] 张永健, 郭学海, 高秀凤, 等. Skp2及p27kip1在原发性胃癌组织的表达及对胃癌细胞增殖、凋亡的影响[J]. 中国实验诊断学, 2023, 27(5): 591-596. [11] ZHANG K, HU K, LI Q, et al. Discovery of novel 1, 3-diphenylpyrazine derivatives as potent S-phase kinase-associated protein 2 (Skp2) inhibitors for the treatment of cancer[J]. J Med Chem, 2023, 66(11): 7221-7242. [12] 陈继新, 廖鹏, 周裕淮, 等. circHERC4通过调节miR-105-5p/Skp2轴抑制结直肠癌细胞的增殖、迁移和侵袭[J]. 临床外科杂志, 2023, 31(8): 733-737. [13] 王海娟, 郑雅宾, 张静. Skp2/p27轴在结直肠癌发生发展中的作用机制研究[J]. 临床外科杂志, 2021, 29(11):1054-1058. [14] BROWN L K, KANAGASABAI T, LI G, et al. Co-targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis[J]. Prostate, 2024, 84(9): 877-887. [15] MARUYAMA T, SAITO K, HIGURASHI M, et al. HMGA2 drives the IGFBP1/AKT pathway to counteract the increase in P27KIP1 protein levels in mtDNA/RNA-less cancer cells[J]. Cancer Sci, 2023, 114(1): 152-163. [16] 张青, 张曙, 刘颖, 等. SPY1和p27kip1在子宫内膜癌中的表达及其临床意义[J]. 临床与病理杂志, 2023, 43(8): 1507-1517. [17] 张媛媛. 脂肪酸-2-羟化酶对人结直肠癌细胞迁移和侵袭的影响及其作用机制[D]. 苏州: 苏州大学, 2021. [18] 高秀凤, 张永健, 郭学海, 等. skp2及p27Kip1蛋白与晚期胃癌患者临床预后的关系[J]. 中国老年学杂志, 2023, 43(23): 5667-5670. [19] HUANG J, TAN X, LIU Y, et al. Knockdown of UBE2I inhibits tumorigenesis and enhances chemosensitivity of cholangiocarcinoma via modulating p27kip1 nuclear export[J]. Mol Carcinog, 2023, 62(5): 700-715. [20] SHIVAROV V, TSVETKOVA G, HADJIEV E, et al. The relevance of HLA class II genes in JAK2 V617F-positive myeloproliferative neoplasms[J]. Hum Immunol, 2023, 84(3): 199-207. [21] LIU D, HOFMAN P. Expression of NOTCH1, NOTCH4, HLA-DMA and HLA-DRA is synergistically associated with T cell exclusion, immune checkpoint blockade efficacy and recurrence risk in ER-negative breast cancer[J]. Cell Oncol: Dordr, 2022, 45(3): 463-477. [22] 安雯, 潘四维, 段石杰, 等. 基于GEO基质评分和免疫评分分析HLA-DRA在胃癌组织中的表达及其临床意义[J]. 中国医科大学学报, 2021, 50(12): 1063-1068. |
[1] | GAN Yujing, HUANG Min. Management of complications of nutrition therapy for elderly critically ill patients [J]. Practical Geriatrics, 2025, 39(5): 433-438. |
[2] | ZHOU Jing. Timing and route selection of nutritional treatment for elderly patients with critical illness [J]. Practical Geriatrics, 2025, 39(5): 439-443. |
[3] | JIANG Jie, ZHOU Dandan, ZHU Baohua. Advances in energy and protein treatment goals for elderly critically ill patients [J]. Practical Geriatrics, 2025, 39(5): 444-449. |
[4] | DUAN Jianfeng, YU Wenkui. Gut microbiota and critical illness in the elderly [J]. Practical Geriatrics, 2025, 39(5): 450-455. |
[5] | ZHANG Jie, WANG Qifeng, MI Weinuo, ZHANG Lina, GHEN Guofang, SUN Yu, XU Shuhang, LIU Chao. The level of vitamin D and the prevalence of autoimmune thyroiditis in rural elderly: a cross-sectional study [J]. Practical Geriatrics, 2025, 39(5): 456-460. |
[6] | ZHANG Yang, YANG Shun, ZANG Liuxue, LU Ziru, YU Zhenfeng, LIU Meiyu. Effects of ropivacaine combined with different concentrations of methylene blue for fascia iliaca block on postoperative analgesia and rehabilitation in patients undergoing hip arthroplasty [J]. Practical Geriatrics, 2025, 39(5): 466-471. |
[7] | HUO Xiaopeng, LI Yang, ZHAO Yafang, LI Chaoyue, LAI Xiaoxing. Current status and influencing factors of depression in the community elderly with cognitive frailty [J]. Practical Geriatrics, 2025, 39(5): 477-481. |
[8] | WANG Guoyu, XU Cen, WANG Jian, WANG Ruzhu. Relationship between the risk of malnutritional and prognosis in elderly patients with acute ST-segment elevation myocardial infarction who underwent percutaneous coronary intervention [J]. Practical Geriatrics, 2025, 39(5): 482-486. |
[9] | HUANG Yuanjie, HUA Dongxu, SUN Jingxian, GU Mingxia, SUN Wei, WANG Lan. Predictive value of plasma calcitonin gene-related peptide level for morning blood pressure surge in elderly patients with primary hypertension [J]. Practical Geriatrics, 2025, 39(5): 497-501. |
[10] | CHEN Lijuan, DONG Dan, LIU Yilin, ZHANG Yi, YU Hehua. Analysis of risk factors for in-hospital death in elderly patients with type 2 diabetes mellitus complicated with severe pneumonia [J]. Practical Geriatrics, 2025, 39(5): 514-518. |
[11] | YAN Xiang, LI Xiaoliang, SONG Hui, GUO Lu, CHEN Shizhao, FAN Juanning, YANG Jing, XU Mei, ZHAO Sizhu, YANG Xiaoguang, CHENG Xianzong, LI Yunming. Analysis of risk factors and construction of risk assessment model for dysphagia in the elderly [J]. Practical Geriatrics, 2025, 39(5): 524-529. |
[12] | ZHANG Meng, JIANG Zhifan, SHEN Chun, XIE Erfu, GUO Lulu, ZHANG Tao. Clinical characteristics and prognosis of rhabdomyolysis in the elderly [J]. Practical Geriatrics, 2025, 39(5): 530-533. |
[13] | SHANG Zhaoming, CHEN Mingquan. Epidemiological characteristics of sepsis in the elderly [J]. Practical Geriatrics, 2025, 39(4): 325-329. |
[14] | ZUO Rui, GU Shuangshuang, WANG Jun. Research progress of exosomes in elderly patients with sepsis: focus on the pathopathological characteristics and clinical challenges in the elderly [J]. Practical Geriatrics, 2025, 39(4): 330-335. |
[15] | SUN Yuxin, CHEN Mingquan. Reaserch advances in enterogenic sepsis in the elderly [J]. Practical Geriatrics, 2025, 39(4): 336-340. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||